Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Dental Research
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Li, H.Y.
Right arrow Articles by Oh, S.B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, H.Y.
Right arrow Articles by Oh, S.B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CAPSAICIN
*EUGENOL
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Eugenol Inhibits K+ Currents in Trigeminal Ganglion Neurons

H.Y. Li1, C.-K. Park1, S.J. Jung2, S.-Y. Choi1, S.J. Lee1, K. Park1, J.S. Kim1 and S.B. Oh*

1 Department of Physiology and Program in Molecular and Cellular Neuroscience, School of Dentistry and Dental Research Institute, Seoul National University, 28-2 Yeongeon-Dong Chongno-Ku, Seoul 110-749, Korea; and
2 Department of Physiology, College of Medicine, Kangwon National University, Chunchon 200-710, Korea


Figure 1
View larger version (14K):
[in this window]
[in a new window]

 
Figure 1. Eugenol inhibited voltage-gated K+ currents in rat trigeminal ganglion neurons. (A) Using pulses from –80 mV to 60 mV for 600 ms with a holding potential of –60 mV, we obtained the representative traces under control, 1 mM eugenol, and wash-out conditions, measured at the points indicated in (B). (B) For time-course recording of voltage-gated K+ currents, we used a depolarizing potential of 20 mV from a holding of –80 mV in 10-second intervals. When trigeminal ganglion neurons were exposed to eugenol (1 mM), the voltage-gated K+ current was readily inhibited in a reversible manner. (C) The dose-response curve of the inhibition of voltage-gated K+ currents by eugenol with the IC50 of 376 ± 90 µM. The number in parentheses represents the number of cells studied.

 

Figure 2
View larger version (14K):
[in this window]
[in a new window]

 
Figure 2. Eugenol inhibited voltage-gated K+ currents in both capsaicin-sensitive and capsaicin-insensitive rat trigeminal ganglion neurons. (A) Representative current traces of voltage-gated K+ currents under control, eugenol (1 mM), and capsaicin (1 µM), respectively, in 2 trigeminal ganglion neurons. Eugenol (1 mM) inhibited voltage-gated K+ currents in both capsaicin-sensitive (left) and capsaicin-insensitive (right) trigeminal ganglion neurons. (B) Representative time-courses of the inhibition of voltage-gated K+ currents by eugenol in capsaicin-sensitive (black circle) and capsaicin-insensitive (white circle) trigeminal ganglion neurons (left). The summary of the inhibition of voltage-gated K+ currents in trigeminal ganglion neurons (right) indicated that eugenol (1 mM)-induced inhibition in capsaicin-insensitive neurons was similar to that obtained in capsaicin-sensitive neurons (mean ± SEM, p > 0.05). The number in parentheses represents the number of cells studied.

 

Figure 3
View larger version (19K):
[in this window]
[in a new window]

 
Figure 3. Inhibition of voltage-gated K+ currents by eugenol does not require TRPV1 activation. (A) Capsazepine (CZP) did not block the inhibition of voltage-gated K+ currents by eugenol in rat trigeminal ganglion (TG) neurons. The representative traces of voltage-gated K+ currents under control, CZP (10 µM), and the combined application of eugenol and CZP (left). The inhibition of voltage-gated K+ currents by the combined application of eugenol and CZP was not significantly different from that of eugenol only (mean ± SEM, p > 0.05) (right), indicating that eugenol-induced voltage-gated K+ current inhibition was TRPV1-independent. The number in parentheses represents the number of cells studied. (B) Representative current traces under control and 1 mM eugenol in Ltk cells (left). Eugenol inhibited hKv1.5 currents in Ltk cells. The summary of K+ current inhibition in trigeminal ganglion neurons and Ltk cells (right). The K+ current inhibition by eugenol in trigeminal ganglion neurons was significantly greater than that in Ltk cells (mean ± SEM, p < 0.05). (Insert) RT-PCR analysis shows no endogenous expression of TRPV1 in Ltk cells. TRPV1 is clearly expressed in trigeminal ganglion neurons. The expected sizes of PCR products were 233 bp (TRPV1) and 293 bp (β-actin). No PCR products were detected with H2O (lane –).

 

Journal of Dental Research, Vol. 86, No. 9, 898-902 (2007)
DOI: 10.1177/154405910708600918


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?